What is Lexicon Pharmaceuticals's net investment in lease?

Lexicon Pharmaceuticals (LXRX) reported net investment in lease of $7.12M in Q1 2026.

How has Lexicon Pharmaceuticals's net investment in lease changed year-over-year?

Lexicon Pharmaceuticals's net investment in lease increased by 53.3% year-over-year, from $4.65M to $7.12M.

What is the long-term trend for Lexicon Pharmaceuticals's net investment in lease?

Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's net investment in lease has grown at a 4.5% compound annual growth rate (CAGR), from $6.41M to $7.32M.

Lexicon Pharmaceuticals LXRX Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

CytokineticsCYTK

——

Zevra Therapeutics, Inc.ZVRA

——

Eton Pharmaceuticals, Inc.ETON

——

Opko HealthOPK

——

Theravance BiopharmaTBPH

——

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$1.02B+273%

Enterprise value$1.01B+219%

P/S14.6×+5.9×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's net investment in lease?: Lexicon Pharmaceuticals (LXRX) reported net investment in lease of $7.12M in Q1 2026.
How has Lexicon Pharmaceuticals's net investment in lease changed year-over-year?: Lexicon Pharmaceuticals's net investment in lease increased by 53.3% year-over-year, from $4.65M to $7.12M.
What is the long-term trend for Lexicon Pharmaceuticals's net investment in lease?: Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's net investment in lease has grown at a 4.5% compound annual growth rate (CAGR), from $6.41M to $7.32M.